Methamphetamine self-administration attenuates hippocampal serotonergic deficits: Role of brain-derived neurotrophic factor

International Journal of Neuropsychopharmacology

Volumn 17, Issue 8, 2014, Pages 1315-1320

  McFadden, Lisa M ^a   Vieira Brock, Paula L ^a   Hanson, Glen R ^a   Fleckenstein, Annette E ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

Brain derived neurotrophic factor; hippocampus; methamphetamine; self administration; serotonin transporter

Indexed keywords

BETA ACTIN; BRAIN DERIVED NEUROTROPHIC FACTOR; METHAMPHETAMINE; SEROTONIN TRANSPORTER; RNA BINDING PROTEIN; SEROTONIN; SERT PROTEIN, RAT; TRITIUM;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG SELF ADMINISTRATION; EXPOSURE; HIPPOCAMPUS; IMMUNOREACTIVITY; MALE; NEUROCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONINERGIC SYSTEM; WESTERN BLOTTING; ANIMAL; DIAGNOSTIC USE; DRUG EFFECTS; METABOLISM; SCINTISCANNING; SYNAPTOSOME;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; HIPPOCAMPUS; MALE; METHAMPHETAMINE; RATS; RNA-BINDING PROTEINS; SELF ADMINISTRATION; SEROTONIN; SYNAPTOSOMES; TRITIUM;

EID: 84927565954     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145714000327     Document Type: Article

References (25)

1. Belcher AM, Feinstein EM, O'Dell SJ, Marshall JF (2008) Methamphetamine influences on recognition memory: comparison of escalating and single-day dosing regimens. Neuropsychopharmacology 33:1453-1463.
2. Benmansour S, Deltheil T, Piotrowski J, Nicolas L, Reperant C, Gardier AM, Frazer A, David DJ (2008) Influence of brainderived neurotrophic factor (BDNF) on serotonin neurotransmission in the hippocampus of adult rodents. Eur J Pharmacol 587:90-98.
3. Braun AA, Herring NR, Schaefer TL, Hemmerle AM, Dickerson JW, Seroogy KB, Vorhees CV, Williams MT (2011) Neurotoxic (+)-methamphetamine treatment in rats increases brain-derived neurotrophic factor and tropomyosin receptor kinase B expression in multiple brain regions. Neuroscience 184:164-171.
4. Cadet JL, Krasnova IN, Ladenheim B, Cai NS, McCoy MT, Atianjoh FE (2009) Methamphetamine preconditioning: differential protective effects on monoaminergic systems in the rat brain. Neurotox Res 15:252-259.
5. Cadet JL, Brannock C, Ladenheim B, McCoy MT, Beauvais G, Hodges AB, Lehrmann E, Wood WH 3rd, Becker KG, Krasnova IN (2011) Methamphetamine preconditioning causes differential changes in striatal transcriptional responses to large doses of the drug. Dose Response 9:165-181.
6. Chang L, Alicata D, Ernst T, Volkow N (2007) Structural and metabolic brain changes in the striatum associated with methamphetamine abuse. Addiction 102 (Suppl. 1):16-32.
7. Daws LC, Munn JL, Valdez MF, Frosto-Burke T, Hensler JG (2007) Serotonin transporter function, but not expression, is dependent on brain-derived neurotrophic factor (BDNF): in vivo studies in BDNF-deficient mice. J Neurochem 101:641-651.
8. Griesbach GS, Hovda DA, Gomez-Pinilla F, Sutton RL (2008) Voluntary exercise or amphetamine treatment, but not the combination, increases hippocampal brain-derived neurotrophic factor and synapsin I following cortical contusion injury in rats. Neuroscience 154:530-540.
9. Guiard BP, David DJ, Deltheil T, Chenu F, Le Maître E, Renoir T, Leroux-Nicollet I, Sokoloff P, Lanfumey L, Hamon M, Andrews AM, Hen R, Gardier AM (2008) Brain-derived neurotrophic factor-deficient mice exhibit a hippocampal hyperserotonergic phenotype. Int J Neuropsychopharmacol 11:79-92.
10. Hilburn C, Nejtek VA, Underwood WA, Singh M, Patel G, Gangwani P, Forster MJ (2011) Is serum brain-derived neurotrophic factor related to craving for or use of alcohol, cocaine, or methamphetamine? Neuropsychiatr Dis Treat 7:357-364.
11. Johnson-Davis KL, Fleckenstein AE, Wilkins DG (2003) The role of hyperthermia and metabolism as mechanisms of tolerance to methamphetamine neurotoxicity. Eur J Pharmacol 482:151-154.
12. Kim DJ, Roh S, Kim Y, Yoon SJ, Lee HK, Han CS, Kim YK (2005) High concentrations of plasma brain-derived neurotrophic factor in methamphetamine users. Neurosci Lett 388:112-115.
13. Kish SJ, Fitzmaurice PS, Boileau I, Schmunk GA, Ang LC, Furukawa Y, Chang LJ, Wickham DJ, Sherwin A, Tong J (2009) Brain serotonin transporter in human methamphetamine users. Psychopharmacology (Berl) 202:649-661.
14. Koshimizu H, Hazama S, Hara T, Ogura A, Kojima M (2010) Distinct signaling pathways of Precursor BDNF and mature BDNF in cultured cerebellar granule neurons. Neurosci Lett 473:229-232.
15. Krasnova IN, Chiflikyan M, Justinova Z, McCoy MT, Ladenheim B, Jayanthi S, Quintero C, Brannock C, Barnes C, Adair JE, Lehrmann E, Kobeissy FH, Gold MS, Becker KG, Goldberg SR, Cadet JL (2013) CREB phosphorylation regulates striatal transcriptional responses in the self-administration model of methamphetamine addiction in the rat. Neurobiol Dis 58:132-143.
16. Lacan G, Hadamitzky M, Kuczenski R, Melega WP (2013) Alterations in the striatal dopamine system during intravenous methamphetamine exposure: Effects of contingent and noncontingent administration. Synapse 67:476-488.
17. Mamounas LA, Altar CA, Blue ME, Kaplan DR, Tessarollo L, Lyons WE (2000) BDNF promotes the regenerative sprouting, but not survival, of injured serotonergic axons in the adult rat brain. J Neurosci 20:771-782.
18. Matsumoto T, Rauskolb S, Polack M, Klose J, Kolbeck R, Korte M, Barde YA (2008) Biosynthesis and processing of endogenous BDNF: CNS neurons store and secrete BDNF, not pro-BDNF. Nat Neurosci 11:131-133.
19. McFadden LM, Hadlock GC, Allen SC, Vieira-Brock PL, Stout KA, Ellis JD, Hoonakker AJ, Andrenyak DM, Nielsen SM, Wilkins DG, Hanson GR, Fleckenstein AE (2012a) Methamphetamine self-administration causes persistent striatal dopaminergic alterations and mitigates the deficits caused by a subsequent methamphetamine exposure. J Pharmacol Exp Ther 340:295-303.
20. McFadden LM, Hunt MM, Vieira-Brock PL, Muehle J, Nielsen SM, Allen SC, Hanson GR, Fleckenstein AE (2012b) Prior methamphetamine self-administration attenuates serotonergic deficits induced by subsequent high-dose methamphetamine administrations. Drug Alcohol Depend 126:87-94.
21. Molteni R, Calabrese F, Cattaneo A, Mancini M, Gennarelli M, Racagni G, Riva MA (2009) Acute stress responsiveness of the neurotrophin BDNF in the rat hippocampus is modulated by chronic treatment with the antidepressant duloxetine. Neuropsychopharmacology 34:1523-1532.
22. O'Dell SJ, Galvez BA, Ball AJ, Marshall JF (2012) Running wheel exercise ameliorates methamphetamine-induced damage to dopamine and serotonin terminals. Synapse 66:71-80.
23. Panenka WJ, Procyshyn RM, Lecomte T, Macewan GW, Flynn SW, Honer WG, Barr AM (2013) Methamphetamine use: A comprehensive review of molecular, preclinical and clinical findings. Drug Alcohol Depend 129:167-179.
24. Reichel CM, Ramsey LA, Schwendt M, McGinty JF, See RE (2012) Methamphetamine-induced changes in the object recognition memory circuit. Neuropharmacology 62:1119-1126.
25. Sekine Y, Ouchi Y, Takei N, Yoshikawa E, Nakamura K, Futatsubashi M, Okada H, Minabe Y, Suzuki K, Iwata Y, Tsuchiya KJ, Tsukada H, Iyo M, Mori N (2006) Brain serotonin transporter density and aggression in abstinent methamphetamine abusers. Arch Gen Psychiatry 63:90-100.